Hello, Fool! | Login | Signup | My Fool
Dec 4, 2008 12:35 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of a new class of antiviral drug treatments called fusion inhibitors.
View Ticker Page (TRMS)
Results 1 - 10 of 12 : 12
Recs
sleepyseth (96.89) Submitted: 11/07/06 4:10 PM : Start Price: $7.97 TRMS Score: -34.28
Buy this company before the earnings announcement. This will be their first quarter of steady positive earnings (actually their second positive quarter ever). The stock is down a lot over the past couple of years, but now the company is actually go...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
1203cc (< 20) Submitted: 7/11/08 11:28 PM : Start Price: $5.91 TRMS Score: -30.38
I'm just here for the dividends
tboneuva (29.82) Submitted: 5/01/08 10:27 AM : Start Price: $5.70 TRMS Score: -22.06
solid health care products company
WERDOSD44 (42.58) Submitted: 3/24/08 4:18 PM : Start Price: $5.09 TRMS Score: -19.14
THIS COMPANIES PROFITS HAVE DOUBLED
djinsanity (77.14) Submitted: 2/10/08 12:42 PM : Start Price: $5.34 TRMS Score: -22.14
Leader in anti-viral drug treatments, and the world will continue to fund this type of research, Leader in anti-HIV drug research.
utosweet (69.40) Submitted: 2/04/08 6:22 PM : Start Price: $5.35 TRMS Score: -20.84
Something must give on this HIV desease.So,this Bio-tech Co. is one of the best @ $6.59 I'm looking for a run-up to $14.00 Buy November 2008.
gdsfgggg (39.95) Submitted: 7/04/07 12:50 PM : Start Price: $5.36 TRMS Score: -14.03
Stellar cash flow. With financials like this the SP is sure to turnaround. Largely owned by institutions so watch for big price moves on the moving averages. On paper it looks golden, let's hope that translates into bags of money.
majakblue (< 20) Submitted: 5/25/07 2:14 PM : Start Price: $5.69 TRMS Score: 16.83
The company appears to be relying on collaborations with big pharma, which sends me a signal that it will stay small and only marginally profitable if at all. It expects only modest growth of its product Fuzion, despite the fact that an HIV targeted...
lcsystem (85.40) Submitted: 4/11/07 7:44 PM : Start Price: $5.59 TRMS Score: -18.86
Down on CEO departure, but solid sales and earnings, good buy opportunity.
f00lmot (< 20) Submitted: 3/16/07 8:48 PM : Start Price: $5.87 TRMS Score: -23.15
looks good
Terms & Conditions
RSS Headlines
Fool UK